Jaguar Health Inc
NASDAQ:JAGX

Watchlist Manager
Jaguar Health Inc Logo
Jaguar Health Inc
NASDAQ:JAGX
Watchlist
Price: 1.09 USD -3.54% Market Closed
Market Cap: 3.8m USD

Net Margin
Jaguar Health Inc

-341.9%
Current
-378%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-341.9%
=
Net Income
-40.3m
/
Revenue
11.8m

Net Margin Across Competitors

No Stocks Found

Jaguar Health Inc
Glance View

Market Cap
4m USD
Industry
Pharmaceuticals

Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. The company is headquartered in San Francisco, California and currently employs 52 full-time employees. The company went IPO on 2015-05-13. The firm is focused on developing plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with gastrointestinal (GI) distress, including chronic and debilitating diarrhea. The firm operates through two segments: human health and animal health. The animal health segment is focused on developing and commercializing prescription and non-prescription products for companion and production animals. Its Canalevia-CA1 is used for chemotherapy-induced diarrhea in dogs. The human health segment is focused on developing and commercializing of human products and the ongoing commercialization of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with human immunodeficiency virus (HIV)/ acquired immunodeficiency syndrome (AIDS) on antiretroviral therapy. Its wholly owned subsidiary is Napo Pharmaceuticals, Inc.

JAGX Intrinsic Value
10.59 USD
Undervaluation 90%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-341.9%
=
Net Income
-40.3m
/
Revenue
11.8m
What is the Net Margin of Jaguar Health Inc?

Based on Jaguar Health Inc's most recent financial statements, the company has Net Margin of -341.9%.

Back to Top